Chimeric Therapeutics Ltd.(AU:CHM)
A$0.01-0.00 (-8.33%)
AU:CHM
Chimeric Therapeutics Ltd. financials statements
A$0.01
At close:-0.00 (-8.33%)
Want to see AU:CHM full AI Analyst Report?
Chimeric Therapeutics Ltd. (CHM) Ratios
13 Followers
Chimeric Therapeutics Ltd. Ratios
AU:CHM's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, AU:CHM's free cash flow was increased by AU$6.94M and operating cash flow was AU$-6.94M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.12 | 0.72 | 0.32 | 0.64 | 2.35 |
| Quick Ratio | 0.12 | 0.72 | 0.32 | 0.64 | 2.44 |
| Cash Ratio | 0.09 | 0.39 | 0.30 | 0.37 | 2.04 |
| Solvency Ratio | -2.09 | -0.48 | -0.90 | -1.49 | -1.63 |
| Operating Cash Flow Ratio | -1.21 | -0.50 | -0.75 | -1.11 | -1.46 |
| Short-Term Operating Cash Flow Coverage | -15.86 | 0.00 | -2.10 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ -7.98M | AU$ -9.07M | AU$ -9.58M | AU$ -7.36M | AU$ 12.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.53 | 0.00 | 0.24 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | -0.09 | 0.00 | 1.46 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | -0.10 | 0.00 | 0.59 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.17 | 10.92 | 6.18 | 3.95 | 1.36 |
| Debt Service Coverage Ratio | -12.32 | -43.54 | -1.92 | -37.07 | -21.54 |
| Interest Coverage Ratio | 0.00 | -71.61 | -37.10 | -38.10 | -22.77 |
| Debt to Market Cap | 0.34 | 0.00 | 0.29 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.01 | 0.63 | -0.05 | 0.19 | 1.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 78.66% | 99.95% | 0.00% | 63.71% |
| EBIT Margin | 0.00% | -254.72% | -165.01% | 0.00% | -556.82% |
| EBITDA Margin | 0.00% | -228.71% | -151.52% | 0.00% | -520.53% |
| Operating Profit Margin | 0.00% | -380.78% | -165.06% | 0.00% | -556.82% |
| Pretax Profit Margin | 0.00% | -260.04% | -218.30% | 0.00% | -601.22% |
| Net Profit Margin | 0.00% | -262.83% | -168.01% | 0.00% | -607.48% |
| Continuous Operations Profit Margin | 0.00% | -262.83% | -168.01% | 0.00% | -607.48% |
| Net Income Per EBT | 100.12% | 101.07% | 76.96% | 85.45% | 101.04% |
| EBT Per EBIT | 224.85% | 68.29% | 132.25% | 102.86% | 107.97% |
| Return on Assets (ROA) | -1470.94% | -48.35% | -82.04% | -115.83% | -45.58% |
| Return on Equity (ROE) | 243.56% | -528.25% | -507.27% | -457.84% | -61.85% |
| Return on Capital Employed (ROCE) | 109.80% | -217.19% | -237.81% | -383.80% | -56.35% |
| Return on Invested Capital (ROIC) | 120.57% | -217.19% | -108.02% | -383.80% | -56.35% |
| Return on Tangible Assets | -1836.43% | -99.09% | -384.02% | -275.80% | -74.90% |
| Earnings Yield | -937.98% | -192.88% | -100.06% | -157.42% | -48.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.87 | 86.13 | 0.00 | 0.98 |
| Payables Turnover | 0.00 | 0.13 | 0.00 | 0.13 | 0.20 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | -1.08 |
| Fixed Asset Turnover | 0.00 | 0.00 | 10887.09 | 0.00 | 163.69 |
| Asset Turnover | 0.00 | 0.18 | 0.49 | 0.00 | 0.08 |
| Working Capital Turnover Ratio | 0.00 | -0.72 | -1.22 | 0.00 | 0.19 |
| Cash Conversion Cycle | 0.00 | -2411.91 | -297913.94 | -2800.51 | -1775.97 |
| Days of Sales Outstanding | 0.00 | 418.58 | 4.24 | 0.00 | 370.67 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | -339.01 |
| Days of Payables Outstanding | 0.00 | 2830.49 | 297918.17 | 2800.51 | 1807.63 |
| Operating Cycle | 0.00 | 418.58 | 4.24 | 0.00 | 31.66 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.35 | -0.54 | -0.01 | -0.04 | -0.04 |
| Free Cash Flow Per Share | 0.00 | -0.54 | 0.00 | -0.04 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | -7275729.00 | -1.00 | -145.43 | -24.45 |
| Capital Expenditure Coverage Ratio | -1.00 | -7275729.00 | -1.00 | -145.43 | -24.45 |
| Operating Cash Flow Coverage Ratio | -15.86 | 0.00 | -2.10 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | -1.83 | -1.01 | 0.00 | -5.03 |
| Free Cash Flow Yield | 0.00% | -134.54% | 0.08% | -99.79% | -41.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.11 | -0.52 | -1.00 | -0.64 | -2.08 |
| Price-to-Sales (P/S) Ratio | 0.00 | 1.36 | 1.68 | 0.00 | 12.65 |
| Price-to-Book (P/B) Ratio | -0.26 | 2.74 | 5.07 | 2.91 | 1.29 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | -0.74 | 1238.23 | -1.00 | -2.42 |
| Price-to-Operating Cash Flow Ratio | -0.19 | -0.74 | -1.66 | -1.01 | -2.52 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.01 | 0.01 | -0.02 | 0.44 |
| Enterprise Value Multiple | -0.23 | 0.04 | -1.16 | -0.39 | -1.08 |
| Enterprise Value | 1.89M | -349.78K | 13.06M | 11.09M | 14.73M |
| EV to EBITDA | -0.23 | 0.04 | -1.16 | -0.39 | -1.08 |
| EV to Sales | 0.00 | -0.09 | 1.75 | 0.00 | 5.63 |
| EV to Free Cash Flow | 0.00 | 0.05 | 1291.77 | -0.68 | -1.08 |
| EV to Operating Cash Flow | -0.17 | 0.05 | -1.73 | -0.68 | -1.12 |
| Tangible Book Value Per Share | -0.25 | -0.67 | -0.01 | -0.02 | 0.03 |
| Shareholders’ Equity Per Share | -0.25 | 0.15 | 0.00 | 0.01 | 0.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.01 | 0.23 | -0.00 | -0.01 |
| Revenue Per Share | 0.00 | 0.29 | 0.01 | 0.00 | 0.01 |
| Net Income Per Share | -0.61 | -0.77 | -0.02 | -0.06 | -0.04 |
| Tax Burden | 1.00 | 1.01 | 0.77 | 0.85 | 1.01 |
| Interest Burden | 2.25 | 1.02 | 1.32 | 1.03 | 1.08 |
| Research & Development to Revenue | 0.00 | 2.46 | 1.36 | 0.00 | 1.98 |
| SG&A to Revenue | 0.00 | 1.78 | 1.21 | 0.00 | 3.34 |
| Stock-Based Compensation to Revenue | 0.00 | 0.27 | 0.08 | 0.00 | 1.21 |
| Income Quality | 0.57 | 0.70 | 0.60 | 0.63 | 0.83 |
Currency in AUD

